Oncology Institute, Inc.
Ticker: 1799191
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 169.77+15.1% | 147.44+8.0% | 136.56+14.0% | 119.80+14.7% | 104.41+4.5% | 99.90+1.3% | 98.58+4.1% | 94.67 |
| Total Income | 169.77+15.1% | 147.44+8.0% | 136.56+14.0% | 119.80+14.7% | 104.41+4.5% | 99.90+1.3% | 98.58+4.1% | 94.67 |
| EXPENSES | ||||||||
| Expenditure | 172.75+12.2% | 153.95+6.5% | 144.62+10.4% | 131.01+14.6% | 114.32+0.5% | 113.75-1.0% | 114.94+2.0% | 112.64 |
| Tax | 0.00 | 0.00 | 0.00+100.0% | -0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | ||||||||
| PBT | -15.75-532.5% | -2.49+84.9% | -16.50+3.7% | -17.14+12.5% | -19.59-21.6% | -16.11-4.1% | -15.48+22.2% | -19.89 |
| Net Profit | -15.75-532.5% | -2.49+84.9% | -16.50+3.0% | -17.01+13.2% | -19.59-21.6% | -16.11-4.1% | -15.48+22.2% | -19.89 |
| KEY METRICS | ||||||||
| OPM % | -1.76%+2.66pp | -4.42%+1.48pp | -5.90%+3.46pp | -9.36%+0.13pp | -9.49%+4.37pp | -13.87%+2.73pp | -16.60%+2.38pp | -18.98% |
| NPM % | -9.28%-7.59pp | -1.69%+10.40pp | -12.09%+2.11pp | -14.20%+4.56pp | -18.76%-2.63pp | -16.13%-0.43pp | -15.70%+5.31pp | -21.01% |
| EPS | -0.13-550.0% | -0.02+85.7% | -0.14+6.7% | -0.15+28.6% | -0.21-16.7% | -0.18-5.9% | -0.17+22.7% | -0.22 |
Corporate Events
Board MeetingTOI
20261Sep
Board Meeting
Brad Hively will not stand for re-election to the Board of D…
SEC Filing ↗ Board MeetingTOI
202617Jun
Board Meeting
Annual Meeting of Stockholders to elect directors, ratify au…
SEC Filing ↗